D-0176-2023 Class II Terminated

Recalled by Nephron Sc Inc — West Columbia, SC

FDA drug recall D-0176-2023 was initiated by Nephron Sc Inc on Jan 13, 2023 and is designated Class II. Reason for recall: Short Fill The recall status is terminated (terminated Oct 11, 2024). Affected quantity: 925,920 vials.

Recall Details

Product Type
Drugs
Report Date
Feb 1, 2023
Initiation Date
Jan 13, 2023
Termination Date
Oct 11, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
925,920 vials

Product Description

S2 Racepinephrine Inhalation Solution, USP 2.25% Bronchodilator 30x0.5 mL Sterile Unit-of-Use Vials each in a foil pouch, Manufactured By: Nephron West Columbia, SC 29172, NDC 0487-5901-99 UPC 3 04875 90199 9

Reason for Recall

Short Fill

Distribution Pattern

Nationwide within the United States including Puerto Rico. Guatamala

Code Information

Lot #: 126461, 126431 Exp. 04/30/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0176-2023
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0176-2023. Report a data issue: hello@regdatalab.com.